5
Diagnostic kits comprised of medical diagnostic reagents, in particular reagents for testing, determining and/or analyzing the level of protein and/or RNA expression in a biological sample derived from an individual, in particular the level of EPH-B4 (ephrin receptor) and/or Ephrin A1 receptor expression in a sample derived from tumor tissue or bodily fluids; diagnostic assays for testing of cells, tissue or bodily fluids for use in patient stratification and disease detection, namely cancer; biological and medical preparations and articles, in particular reagents for use in diagnostic and clinical tests, diagnostic biomarker reagents for medical purposes, in particular for enabling treatment decisions in connection with cancer patients, in particular with the administration of erythropoietin; pharmaceuticals and therapeutics, in particular for use in precision medicine; none of the aforesaid being for veterinary purposes, for dealing with insects or vermin, not for being in relation to wound care
44
Medical testing for diagnostic or treatment purposes; molecular testing for medical purposes; consulting services in the field of diagnostic medical testing and precision medicine, in particular in relation with treatment decisions and the administration of cancer drugs; health care consulting in the field of cancer treatment; providing online information, via the internet and mobile applications, in the fields of genetic and molecular testing and cancer diagnosis and treatment; medical and pharmaceutical consulting services relating to patient specific medical treatment options, in particular cancer treatment options; medical consulting services relating to the treatment and diagnosis of individuals; providing pharmaceutical and medical information, in particular information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals, in particular in connection with the administration of erythropoietin; medical consulting services in the fields of patient treatment and treatment protocols, diagnostic molecular testing, drug safety, dosage assessment, in particular in the field of cancer treatment therapy for others; none of the aforesaid being for veterinary purposes, for dealing with insects or vermin, not for being in relation to wound care